<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>OAR@UM Collection:</title>
    <link>https://www.um.edu.mt/library/oar/handle/123456789/34873</link>
    <description />
    <pubDate>Fri, 17 Apr 2026 17:20:08 GMT</pubDate>
    <dc:date>2026-04-17T17:20:08Z</dc:date>
    <item>
      <title>Imaging inflammatory bowel disease</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/13988</link>
      <description>Title: Imaging inflammatory bowel disease
Authors: Vassallo, Pierre
Abstract: Inflammatory bowel disease (IBD) refers to a group of&#xD;
idiopathic conditions of the gastrointestinal tract, the most&#xD;
common of which are Crohn’s disease and ulcerative colitis&#xD;
(UC). Approximately one in every four to six patients with IBD&#xD;
presents in childhood or adolescence. The incidence of IBD has&#xD;
been increasing over the past 40 years.</description>
      <pubDate>Wed, 01 Jan 2014 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/13988</guid>
      <dc:date>2014-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>The Synapse : the medical professionals' network : volume 13 : issue 3</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/13963</link>
      <description>Title: The Synapse : the medical professionals' network : volume 13 : issue 3
Editors: Galea, Wilfred; Ellul, Ian C.
Abstract: Apart from the normal articles regarding medicine, this issue contains also the following: Editorial : European Parliament Elections - Quo Vadis ?- Ian C. Ellul; A day in the life of a ... physiotherapy student - Yimeng Zhang (MMSA); The newly elected Executive Team - Matthew Zarb (MPSA); Keeping a family medical tradition going (Francesca Chircop) - Marika Azzopardi</description>
      <pubDate>Wed, 01 Jan 2014 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/13963</guid>
      <dc:date>2014-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Oncogene addiction might be the Achilles heel in cancer : part 1</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/13962</link>
      <description>Title: Oncogene addiction might be the Achilles heel in cancer : part 1
Authors: Grech, Alfred; Baldacchino, Alexandra
Abstract: Multiple and complex genetic and epigenetic abnormalities&#xD;
underlie the multistage transformation of normal cells into&#xD;
cancerous ones. Among these abnormalities are the activation&#xD;
of oncogenes and loss of function of tumour suppressor&#xD;
genes. Besides these abnormalities, it is becoming evident that&#xD;
specific cancers are dependent on one or a few genes for their&#xD;
malignant phenotype, and this could be their ‘Achilles heel’. This&#xD;
survival dependency of cancer cells on an activated oncogene&#xD;
or inactivation of tumour suppressor gene is called ‘oncogene&#xD;
addiction’ and may well be a potential way to provide more&#xD;
rational molecular targeted therapy. This strategy needs to&#xD;
integrate new approaches into the clinical setting in order to&#xD;
characterise the state of oncogene addiction and accordingly,&#xD;
apply more effective and selective anti-cancer therapies.
Description: Part 2 of the article can be found through this link:&#xD;
&#xD;
https://www.um.edu.mt/library/oar//handle/123456789/13958</description>
      <pubDate>Wed, 01 Jan 2014 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/13962</guid>
      <dc:date>2014-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>New modalities for cancer therapy</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/13961</link>
      <description>Title: New modalities for cancer therapy
Authors: Cauchi, Maurice N.
Abstract: The classical ways of combating cancer have included&#xD;
surgery, radiotherapy, and chemotherapy. More recently,&#xD;
immunotherapy has been added to this armamentarium on&#xD;
the premise that cancer cells differ antigenically from normal&#xD;
cells, and therefore can become the target of immune cells or&#xD;
specifically (mono-clonally) engineered antibodies.&#xD;
Apart from surgery, which aims to remove as much of the&#xD;
tumour as technically possible, all other therapies assume that&#xD;
tumour cells are destroyed preferentially compared to normal&#xD;
tissue, that is, the therapeutic ratio is acceptable, and that in&#xD;
spite of side effects, which can often be not inconsiderable, the&#xD;
benefits derived from these therapies are significant.</description>
      <pubDate>Wed, 01 Jan 2014 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/13961</guid>
      <dc:date>2014-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

